Last10K.com

Gemphire Therapeutics Inc. (GEMP) SEC Filing 8-K Material Event for the period ending Friday, December 6, 2019

Gemphire Therapeutics Inc.

HISTORY TOOLS
CIK: 1638287 Ticker: GEMP

View differences made from one to another to evaluate Gemphire Therapeutics Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gemphire Therapeutics Inc..

Continue

Assess how Gemphire Therapeutics Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Gemphire Therapeutics Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Gemphire Therapeutics Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: GEMP
CIK: 1638287
Form Type: 8-K Corporate News
Accession Number: 0001558370-19-011410
Submitted to the SEC: Fri Dec 06 2019 4:03:24 PM EST
Accepted by the SEC: Fri Dec 06 2019
Period: Friday, December 6, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/gemp/0001558370-19-011410.htm